tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF

Compare ALK-abello (AKBLF) vs. Competitors

Compare
14 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$33.45
$7.35B
45.34
55.22%
0 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$15.48
$1.82B
-40.55
19.02%
2 Buy
1 Hold
0 Sell
Moderate Buy
Inovio Pharmaceuticals
$1.63
$111.99M
-0.63
-22.01%
2 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$3.51
$380.29M
-2.54
46.86%
3 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$11.34
$595.58M
8.76
2.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$148.68
$282.32B
20.13
41.94%
1 Buy
4 Hold
1 Sell
Hold
Bristol-Myers Squibb
$55.05
$112.07B
18.59
-6.92%
8 Buy
11 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
33.45
11.73
53.97%
DVAX
Dynavax
15.49
2.55
19.67%
INO
Inovio Pharmaceuticals
1.63
-0.36
-18.09%
ACRS
Aclaris Therapeutics
3.51
1.11
46.25%
EBS
Emergent Biosolutions
11.34
0.85
8.10%
NVS
Novartis
148.68
46.31
45.23%
BMY
Bristol-Myers Squibb
55.05
-2.02
-3.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts